Global B2B Pharmaceutical Marketplace Β· Sourcing Β· Named-Patient Access
πŸ’¬ WhatsApp Β· Sign in Β· Register

Government & Institutional Tender Supply

Tender-ready pharmaceutical supply for health ministries, central medical stores, hospital groups, military and police health services, and donor-funded programmes across Asia, Africa, the Middle East and Latin America.

Mitul Agarwal
Written by Mitul Agarwal Β· B.Pharm, MBA
Founder & Head of Business Development Β· 25+ years in international pharmaceutical BD&L

Most tender bids are lost on paperwork, not on price

In our experience across public procurement in emerging markets, the lowest quoted price wins far less often than people assume. Bids are disqualified at technical evaluation β€” before price is even opened β€” because one document was missing, out of date, or issued by an authority the tender board does not recognise.

The most common causes of technical rejection we see are: a Certificate of Pharmaceutical Product (CoPP) not legalised through the right embassy chain, a GMP certificate from a regulator outside the tender's accepted list, shelf life at the point of delivery falling below the specified minimum, and pack presentation or labelling language that does not match the tender schedule.

We structure the technical file before the commercial offer, so the bid survives evaluation.

Typical disqualification reasons
  • CoPP missing, expired, or not legalised
  • GMP certificate from a non-accepted regulator
  • Residual shelf life below tender minimum at delivery
  • Labelling language or pack size mismatch
  • No batch-traceable Certificate of Analysis
  • Bid security / performance bond incorrectly formatted
  • Site not covered by a current regulatory inspection

Who we supply

Buyer type What they typically need from us
Health ministries & central medical stores Full technical dossier pack, CoPP, pre-shipment inspection support, staggered delivery schedules against an annual framework
Public & private hospital groups Formulary-matched generics and biosimilars, hospital pack presentations, consignment and emergency top-up supply
Donor-funded & humanitarian programmes WHO prequalified or SRA-approved sources where the funding rules require it, GS1 compliant labelling, donor-format documentation
Military, police & para-statal health services Long-shelf-life stock, field-durable packaging, sealed-bid documentation, confidentiality on quantities
Licensed importers bidding into public tenders Back-to-back manufacturer commitment, price validity matched to tender validity, dossier access for local registration

How we work a tender with you

1
Tender document review

We read the actual tender schedule β€” not just the item list. Accepted regulators, residual shelf life, pack presentation, labelling language, bid security format, delivery Incoterm and penalty clauses all change which manufacturers can legitimately bid.

2
Eligible source shortlist

We consult manufacturers whose approvals actually satisfy that tender, and confirm capacity against your volume and delivery window before quoting. A source that cannot hold the delivery schedule is not a source.

3
Technical file assembly

CoPP, GMP certificate, manufacturing licence, site inspection status, method of analysis, finished-product specification, stability data summary, and batch-traceable CoA β€” compiled in the tender's required order and format.

4
Commercial offer with locked validity

Price held for the tender validity period, not for two weeks. We fix Incoterm, currency, payment instrument (LC, advance, or credit terms) and freight mode up front so the award does not reopen the negotiation.

5
Award-to-shipment execution

Performance bond, pre-shipment inspection (SGS, Bureau Veritas, Intertek or the nominated agency), batch release documents, legalisation chain, and shipment against the agreed delivery schedule.

6
Framework and repeat supply

Annual and multi-year frameworks supported with call-off scheduling, buffer stock planning and price-revision mechanics tied to API cost movement rather than ad-hoc renegotiation.

Documentation we provide as standard

  • Certificate of Pharmaceutical Product (CoPP), WHO format
  • Valid GMP certificate and manufacturing licence
  • Free Sale Certificate where required
  • Batch-traceable Certificate of Analysis
  • Finished product specification and method of analysis
  • Stability study summary and shelf-life justification
  • TSE/BSE and residual solvent statements
  • Artwork, labelling and insert proofs for approval
  • Packing list, invoice and certificate of origin
  • Legalisation via Chamber of Commerce and embassy chain

See the full documentation and quality pack Β· Country tender & registration guides

On manufacturer identity

For a public tender we disclose the manufacturing site, its regulatory approvals and its full technical file β€” because the tender board requires it and the bid cannot be evaluated without it. What we do not publish is our source list on this website. If your requirement is at enquiry stage rather than tender stage, we share approvals, certifications and country of manufacture first. Where the requirement is firm and specific, manufacturer disclosure under a confidential disclosure agreement can be arranged on request, considered case by case. That protects both you and the manufacturer from speculative price shopping.

Have a live tender or framework requirement?

Send us the tender reference, item schedule and closing date. We will tell you honestly whether we can field a compliant bid before you spend time on it.

Submit Tender Requirement Talk to our team

Frequently Asked Questions

Most public tenders require a Certificate of Pharmaceutical Product (CoPP) in WHO format, a valid GMP certificate, the manufacturing licence, a batch-traceable Certificate of Analysis, the finished product specification and method of analysis, a stability summary supporting the claimed shelf life, and labelling artwork for approval. Many also require legalisation of the CoPP through the importing country's embassy, plus bid security in a specified format.

Bids fail technical evaluation most often because a required certificate is missing, expired or not legalised through the correct chain; because the GMP certificate comes from a regulator not on the tender's accepted list; because residual shelf life at the point of delivery falls below the tender minimum; or because pack size and labelling language do not match the tender schedule. All of these are avoidable if the technical file is built before the commercial offer.

A Certificate of Pharmaceutical Product is issued by the regulatory authority of the exporting country in a format recommended by the WHO. It confirms the product is licensed or licensable there, states whether it is actually marketed in that country, and confirms the manufacturing site complies with GMP. Most importing regulators and tender boards treat it as the primary proof of regulatory standing, which is why an expired or improperly legalised CoPP is a frequent cause of rejection.

Yes, where the product and source can meet the specific funding rules. Donor-funded procurement commonly restricts eligibility to WHO prequalified products, products approved by a stringent regulatory authority, or products cleared by an expert review panel, and often adds GS1 labelling and serialisation requirements. We check eligibility against the funding mechanism's current rules before quoting, rather than after award.

Yes. A tender cannot be technically evaluated without the manufacturing site, its approvals and its technical file, so all of that is disclosed in the bid. At earlier enquiry stage we share regulatory approvals, certifications and country of manufacture first. Where the requirement is firm and specific, manufacturer disclosure under a confidential disclosure agreement can be arranged on request, considered case by case.

It depends mainly on whether the documentation already exists in the required form. Where a manufacturer holds a current CoPP and GMP certificate for the exact presentation, a bid can be assembled quickly. Where a fresh CoPP, new artwork or embassy legalisation is needed, that step alone can take several weeks. This is why we ask for the tender closing date at first contact β€” so we can tell you honestly whether it is achievable.

Yes. Framework and rate-contract supply is supported with scheduled call-offs, buffer stock planning at origin, and a price-revision mechanism linked to API cost movement and freight rather than open renegotiation at each call-off.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.